Artgen Biotech PJSC (MOEX:ISKJ)
Russia flag Russia · Delayed Price · Currency is RUB
59.54
+0.84 (1.43%)
At close: Jul 8, 2022

Artgen Biotech PJSC Cash Flow Statement

Millions RUB. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
0.5396.95214.91168.8646.1211.63
Depreciation & Amortization
117.48124.3884.3570.953.4879.84
Other Amortization
17.6917.690.36--1.44
Loss (Gain) From Sale of Assets
0.440.92-0.520.5875.3126.51
Loss (Gain) on Equity Investments
25.325.973.524.17-23.145.21
Provision & Write-off of Bad Debts
11.998.2911.9813.4315.4112.73
Other Operating Activities
49.9925.52234.66112.1384.9199.99
Change in Accounts Receivable
-139.57-153.54-28.52-92.4686.78.72
Change in Inventory
27.4822.13-21.58-1.5116.4-21.54
Change in Accounts Payable
154.5822.43-17.32138.75-134.956.27
Operating Cash Flow
265.91190.75481.83434.85220.3280.8
Operating Cash Flow Growth
-30.55%-60.41%10.80%97.39%-21.55%421.32%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-169.07-170.39-99.68-204.29-135.93-153.3
Cash Acquisitions
-78.19-25.58-4.88--78.96-
Investment in Securities
3.93-5.18-0.17-46.86-66.1-71.49
Other Investing Activities
51.1459.552.5527.045.486.12
Investing Cash Flow
-418.2-288.25-171.31-216.97-346.78-252.25

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-300--196319.23
Long-Term Debt Repaid
--70.4-122.78-83.76-14.19-194.64
Lease Payments
-24.2-25.45-39.62-27.04-12.15-17.14
Net Debt Issued (Repaid)
272.28229.6-122.78-83.76181.81124.59
Issuance of Common Stock
-14.12-38.8943.83.49
Repurchase of Common Stock
-2.33--35.96---
Common Dividends Paid
-67.22-56.21-140.69-104.23--
Other Financing Activities
358.08-29.68-47.31274.03-87.3-69.11
Financing Cash Flow
560.81157.83-346.74124.94138.3158.96

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.831.69-5.380.46-3.46-1.61
Miscellaneous Cash Flow Adjustments
----0-
Net Cash Flow
407.762.02-41.59343.288.3785.9

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
96.8420.36382.16230.5684.37127.51
Free Cash Flow Growth
-68.81%-94.67%65.75%173.26%-33.83%-
Free Cash Flow Margin
5.51%1.19%25.12%16.85%7.42%10.80%
Free Cash Flow Per Share
1.300.275.132.490.971.59
Levered Free Cash Flow
-44.39-171.69197.36-28.18-139.31-12.27
Unlevered Free Cash Flow
30.82-115.6256.772.59-96.9219.4
Free Cash Flow After Leases
72.64-5.09342.53203.5172.23110.36

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
114.0883.2791.3552.148.650.71
Cash Income Tax Paid
2.964.195.824.643.835.71
Change in Working Capital
42.49-108.98-67.4244.78-31.7943.46